Welcome to our dedicated page for Genius Sports SEC filings (Ticker: GENI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Genius Sports Limited (GENI) filings document foreign private issuer disclosures for a sports data, betting technology and media technology company. Its Form 6-K reports include interim financial statements, management discussion and analysis, earnings press releases, guidance-related updates and material-event disclosures tied to the company’s global sports, betting and media ecosystem.
Governance and capital-structure filings cover annual general meeting notices and results, ordinary-share voting matters, director elections, auditor and financial-statement approvals, director and officer share purchases, registration-statement references, material agreements and ordinary-share capital disclosures.
Genius Sports Limited ownership disclosure: NFL Enterprises LLC reports beneficial ownership of 15,344,471 ordinary shares as of December 31, 2025, representing 6.43% of the class. The total includes 14,500,000 ordinary shares issuable upon exercise of penny warrants exercisable within 60 days and 844,471 ordinary shares.
The filing cites 238,718,120 ordinary shares outstanding as the base for the percentage, per the issuer's disclosure referenced in the filing. Signature on the amendment is by Danielle Bastardi, Chief Accounting Officer, dated February 17, 2026.
Genius Sports Limited reported that its leadership team has bought more of the company’s stock. During the week ended February 13, 2026, certain members of management and the Board of Directors, including Co‑Founder and Chief Executive Officer Mark Locke, Chairman Kenneth Kay, and the Legend Founder, purchased an aggregate of approximately 1.4 million of Genius Sports’ ordinary shares. These transactions increase the personal share ownership of key insiders, aligning them more closely with other shareholders.
Genius Sports Limited plans to acquire Legend, a global digital sports and gaming media network, in a Transaction valued at up to $1.2 billion, including $900 million at closing and up to $300 million of earnout tied to profitability and cash flow targets.
Upfront consideration includes $800 million in cash and $100 million in stock, partly financed by a committed $850 million senior secured term loan and a $220 million revolving credit facility. Genius expects the deal to be immediately accretive to Group Adjusted EBITDA margins and Free Cash Flow conversion, targeting about $1.1 billion in 2026 pro forma Group Revenue and $320–330 million in Group Adjusted EBITDA. Closing is subject to customary conditions and regulatory approvals.
Genius Sports Ltd received a new large shareholder disclosure. Investment firm Voss Capital, together with related funds and managing member Travis W. Cocke, reported beneficial ownership of 12,125,000 Ordinary Shares of Genius Sports, representing approximately 5.08% of the company’s 238,718,120 shares outstanding as of September 30, 2025.
The filing breaks this out as 2,500,000 shares held by Voss Value Master Fund, 400,000 shares held by Voss Value-Oriented Special Situations Fund, and 9,225,000 shares in accounts managed by Voss Capital. The group filed on a Schedule 13G and certified that the securities were not acquired and are not held for the purpose of changing or influencing control of Genius Sports, indicating a passive investment stance.
A security holder of Genius Sports (GENI) filed a notice of proposed sale of up to 193,514 common shares, with an aggregate market value of $1,993,232.90. The shares are planned to be sold through Fidelity Brokerage Services LLC on the NYSE around 01/12/2026. These shares were acquired on 01/06/2026 through restricted stock vesting as compensation from the issuer. The filing notes that there were 214,097,454 shares of this class outstanding, giving context for the size of the planned sale.
Nicholas Taylor filed a Rule 144 notice to sell 199,719 shares of GENI common stock. The planned sale is through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $2,084,826.70 based on the figures in the form, and the company had 214,097,454 shares outstanding. The shares being sold were acquired on 01/07/2026 through restricted stock vesting from the issuer as compensation, with payment also dated 01/07/2026.
The form also reports that during the past three months, Nicholas Taylor sold 162,737 common shares for gross proceeds of $1,763,526.91. By signing, the selling holder represents they are not aware of any material adverse, non-public information about the issuer’s current or prospective operations.
Genius Sports insider Mark A. Locke has filed a notice to sell 53,679 shares of common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $556,087.60. The shares are listed on the NYSE, and the approximate sale date indicated is 01/07/2026.
The 53,679 shares to be sold were acquired on 01/06/2026 via restricted stock vesting from the issuer as compensation. The notice also reports prior sales over the past three months, including 131,608 common shares sold on 11/10/2025 and 91,724 common shares sold on 01/06/2026. Shares of the issuer outstanding were reported as 214,097,454.
A holder of GENI common stock has filed a Rule 144 notice to sell 91,724 shares. The proposed sale is through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value listed as 995,132.02. The filing shows 214,097,454 common shares outstanding for the issuer.
The 91,724 shares to be sold were acquired on 01/05/2026 via restricted stock vesting from the issuer as compensation, with payment also dated 01/05/2026. The notice also reports that Mark Locke sold 131,608 common shares on 11/10/2025 for gross proceeds of 1,368,736.36 during the prior three months.
Genius Sports (GENI) insider Jack Davison filed a notice of proposed stock sales under Rule 144. The filing covers the planned sale of 177,897 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $1,930,040.13, at a time when 214,097,454 shares were outstanding. These shares were acquired on 01/05/2026 via restricted stock vesting from the issuer as compensation, with the same date listed for payment. The filing also notes prior sales by Davison over the past three months, including 400,673 common shares sold on 11/10/2025 for gross proceeds of $4,167,039.27 and 202,876 common shares sold on 01/05/2026 for gross proceeds of $2,253,729.20.
A holder of GENI common stock filed a notice to sell shares under Rule 144. The filing covers 202,876 common shares, to be sold through Fidelity Brokerage Services LLC, with an aggregate market value of $2,253,729.20. These shares relate to a recent restricted stock vesting on 01/02/2026, received from the issuer as compensation on that date.
The notice identifies the intended trading market as the NYSE, with an approximate sale date of 01/05/2026. It also discloses that the same seller previously sold 400,673 common shares on 11/10/2025, generating $4,167,039.27 in gross proceeds. The filing reports that 214,097,454 common shares were outstanding for the issuer at the time referenced.